Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2011 by Northwestern University.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Northwestern University
ClinicalTrials.gov Identifier:
NCT00089284
First received: August 4, 2004
Last updated: April 11, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2012
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)